Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
Type:
Application
Filed:
March 13, 2013
Publication date:
July 18, 2013
Applicant:
UNIVERSITY OF WA CENTER FOR COMMERCIALIZATION
Inventor:
UNIVERSITY OF WA CENTER FOR COMMERCIALIZATION
Abstract: Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
Type:
Application
Filed:
March 13, 2013
Publication date:
July 18, 2013
Applicant:
UNIVERSITY OF WA CENTER FOR COMMERCIALIZATION
Inventor:
UNIVERSITY OF WA CENTER FOR COMMERCIALIZATION
Abstract: Radiolabeled annexin and modified annexin conjugates useful for imaging vascular thrombi are described. Methods for making and using such radiolabeled annexin conjugates are also provided.
Type:
Grant
Filed:
July 26, 1996
Date of Patent:
October 19, 1999
Assignees:
NeoRx Corporation, University of WA
Inventors:
Sudhakar Kasina, John M. Reno, Alan R. Fritzberg, Jonathan Tait
Abstract: Vitamin B.sub.12 receptor modulating agents capable of modulating cell surface receptors by affecting the cell surface receptor trafficking pathway are disclosed. The vitamin B.sub.12 receptor modulating agents are comprised of a covalently bound rerouting moiety and targeting moiety linked by a water-solublizing linker.
Type:
Grant
Filed:
October 19, 1995
Date of Patent:
November 24, 1998
Assignees:
Receptagen Corporation, University of WA
Inventors:
A. Charles Morgan, Jr., D. Scott Wilbur, Pradip M. Pathare
© 2024 Justia
